Delphinidin diminishes in vitro interferon-γ and interleukin-17 producing cells in patients with psoriatic disease
Authors:
- Sotirios G. TsiogkasSTSotirios G. Tsiogkas
- Dimitrios N. SkyvalidasDSDimitrios N. Skyvalidas
- Eleni PatrikiouEPEleni Patrikiou
- Niki NtavariNNNiki Ntavari
- Athina Ioanna DaponteADAthina Ioanna Daponte
- Maria G. GrammatikopoulouMGMaria G. Grammatikopoulou
- Efthimios DardiotisEfthimios Dardiotis
- Aggeliki-Victoria Roussaki-SchulzeARAggeliki-Victoria Roussaki-Schulze
- Lazaros I. SakkasLSLazaros I. Sakkas
- Efterpi ZafiriouEZEfterpi Zafiriou
- Dimitrios P. BogdanosDimitrios P. Bogdanos
- 25 November 2021
- journal article
- research article
- Published by Springer Nature in Immunologic Research
- Vol. 70 (2) , 161-173
Abstract
The anthocyanidin delphinidin reduces psoriasiform lesions and inflammatory mediators in human cell culture systems. Its role in psoriatic disease has not yet been investigated. We assessed delphinidin’s in vitro immunomodulatory effect on ex vivo stimulated peripheral blood mononuclear cells (PBMCs) from 50 individuals [26 with psoriasis, 10 with psoriatic arthritis (PsA) and 14 healthy controls (HCs)]. Cells were either left untreated or stimulated with PMA plus ionomycin in the presence or absence of delphinidin. Intracellular production of interferon-γ (IFNγ), interleukin-17A (IL-17A), and interleukin-10 (IL-10) was measured flow cytometrically. Delphinidin dose-dependently reduced IFNγ+ T cells from patients and HCs. The mean IFNγ decrease in CD4+ T subpopulations was 42.5 ± 28% for psoriasis patients, 51.8 ± 21.5% for PsA patients and 49 ± 17% for HCs (p < 0.001 for all). Similarly, IFNγ reduction in CD8+ T cells was 34 ± 21.6% for psoriasis patients, 47.1 ± 22.8% for PsA and 44.8 ± 14.3% for HCs (P < 0.001 for all). An inhibitory effect of delphinidin was also noted in IFNγ producing NKs and NKTs from psoriasis individuals. Delphinidin also significantly decreased IL-17+ CD4+ T cells in all tested subjects, with marginal effect on the increase of IL-10-producing T regulatory subsets. In conclusion, delphinidin exerts a profound in vitro anti-inflammatory effect in psoriasis and psoriatic arthritis by inhibiting IFNγ+ innate and adaptive cells and T helper (Th) 17 cells. If this effect is also exerted in vivo, delphinidin may be regarded as a nutraceutical with immunosuppressive potential.Keywords
This publication has 45 references indexed in Scilit:
- Estrogen Receptor α Signaling in T Lymphocytes Is Required for Estradiol-Mediated Inhibition of Th1 and Th17 Cell Differentiation and Protection against Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2011
- Delphinidin, a specific inhibitor of histone acetyltransferase, suppresses inflammatory signaling via prevention of NF-κB acetylation in fibroblast-like synoviocyte MH7A cellsBiochemical and Biophysical Research Communications, 2011
- Estrogen Receptor Alpha as a Key Target of Red Wine Polyphenols Action on the EndotheliumPLOS ONE, 2010
- IFN-γ Regulates the Requirement for IL-17 in Proteoglycan-Induced ArthritisThe Journal of Immunology, 2009
- Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinaseCarcinogenesis, 2009
- Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-αBiochemical Pharmacology, 2009
- Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global AssessmentJournal of the American Academy of Dermatology, 2004
- Delphinidin, an active compound of red wine, inhibits endothelial cell apoptosis via nitric oxide pathway and regulation of calcium homeostasisBritish Journal of Pharmacology, 2003
- Bioavailability of anthocyanidin-3-glucosides following consumption of red wine and red grape juiceCanadian Journal of Physiology and Pharmacology, 2003
- Three-Color Flow Cytometry Detection of Intracellular Cytokines in Peripheral Blood Mononuclear Cells: Comparative Analysis of Phorbol Myristate Acetate-Ionomycin and Phytohemagglutinin StimulationClinical and Diagnostic Laboratory Immunology, 2001